Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01411995 · ClinicalTrials.gov registry record · NA

Cervical Lidocaine for Intrauterine Device Insertion Pain

A NA study, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
200
Enrollment target

NCT01411995 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 200 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01411995, a NA study, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
200 participants
Enrollment target

Study Summary

The aim of this study is to evaluate intracervical lidocaine gel as a means to decrease pain associated with intrauterine device (IUD) insertion. They will be randomized to either placebo (inert water based lubricating gel) or 2% lidocaine gel to be placed intracervically via angio-catheter just before intrauterine device insertion. Anticipated pain scores will be assessed using a visual analog scale prior to insertion. Using the same pain scale, patients will again be asked at the end of the procedure to rate their pain.

Interventions

  • DRUG 2% lidocaine gel
  • DRUG Water based lubricant

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2011-08
Est. Completion 2011-12
Phase NA

What the Registry Record Tells You About NCT01411995

The ClinicalTrials.gov registry entry for NCT01411995 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which 2% lidocaine gel is the first listed.

NCT01411995 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01411995 about?

NCT01411995 is a clinical study titled "Cervical Lidocaine for Intrauterine Device Insertion Pain". The aim of this study is to evaluate intracervical lidocaine gel as a means to decrease pain associated with intrauterine device (IUD) insertion. They will be randomized to either placebo (inert water based lubricating gel) or 2% lidocaine gel to be placed intracervically via angio-catheter just bef...

What is the current status of trial NCT01411995?

This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2011-08. Estimated completion is 2011-12.

What interventions are being tested in trial NCT01411995?

The interventions under investigation include: 2% lidocaine gel (DRUG), Water based lubricant (DRUG).

Who is sponsoring clinical trial NCT01411995?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.